For example, Arul M. Chinnaiyan et al. demonstrated that augmenting tumor-specific MHC-I expression increases the number of functional CD8+ T cells within the tumor and slows tumor progression in several syngeneic mouse models [28]. This evidence concerns the gene CD8A and neoplasm.